Stay updated with breaking news from Fred Schwarzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IGM Biosciences Appoints George Gauthier as Chief Commercial OfficerMr. Gauthier Brings 20 Years of Global Commercial Experience in the Life Sciences Industry - read this article along with other careers information, tips and advice on BioSpace
IGM Biosciences Appoints Lisa Decker, Ph.D., as Chief Business Officer – Ms. Decker Brings 20 Years of Development Experience in the Life Sciences Industry – March 15, 2021 07:00 ET | Source: IGM Biosciences IGM Biosciences Mountain View, California, UNITED STATES MOUNTAIN VIEW, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (IGM), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced the appointment of Lisa L. Decker, Ph.D., to the newly created posit...
Medivir enters into exclusive licensing agreement with IGM Biosciences for birinapant - Medivir to Receive an Upfront Payment, as Well as Milestone Payments and Royalties - IGM to Develop Birinapant in Combination with IGM-8444 for the Treatment of Solid Tumors News provided by Share this article Medivir AB (publ) (Nasdaq Stockholm: MVIR) today announced that it has entered into an exclusive licensing agreement, through which IGM Biosciences, Inc. (Nasdaq: IGMS), will receive global, exclusive development rights for birinapant, a clinical-stage SMAC mimetic that binds to and degrades Inhibi...
Search jobs AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development SAN DIEGO--(BUSINESS WIRE)--AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation, today announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences for COVID-19 therapy development. Using its novel yeast display system and large diverse human antibody libraries, AvantGen has identified a pane...